Does anticoagulation prophylaxis reduce the rate of venous thromboembolism in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy?

Br J Haematol. 2022 Apr;197(2):e24-e25. doi: 10.1111/bjh.17931. Epub 2021 Oct 28.

Author

Wing H Tong^{1

2}

Affiliations

¹ Department of Public Health and Primary Care (PHEG), Leiden University Medical Center, Leiden, The Netherlands.
² Argos Zorggroep "DrieMaasStede", Center for Specialized Geriatric Care, Schiedam, The Netherlands.

PMID: 34713438
DOI: 10.1111/bjh.17931

No abstract available

Keywords: adult acute lymphoblastic leukaemia; asparaginase; biostatistics; thrombosis.

Publication types

Letter

MeSH terms

Adult
Anticoagulants / therapeutic use
Antineoplastic Agents* / therapeutic use
Asparaginase / adverse effects
Blood Coagulation
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control

Substances

Anticoagulants
Antineoplastic Agents
Asparaginase